Liposomal iron

Name: Liposomal iron
Brand: humanpeople
SKU: 100010522
Price: 23.5 GBP
Availability: InStock

25mg

£23.50

Product variants

Highly absorbable liposomal iron. Reduces gastrointestinal issues normally associated with iron supplements.

Quantity

28 day supply (£0.83 / day)

Purchase options

One-time purchase £23.50

Delivered every 4 weeks Added to your personalised stack. Billed and delivered every 4 weeks. £23.50

Tax included. Shipping calculated at checkout.

View full details

Vegan

Vegetarian

Non-GMO

GMP

Gluten Free

The basics

High absorption with or without food, tasteless liposomal iron. Removes gastrointestinal discomfort and constipation issues.

Enhanced Absorption: Utilises liposomal encapsulation to significantly improve iron bioavailability, ensuring efficient uptake by the body.
Gentle on the Stomach: The protective liposomal coating minimises gastrointestinal side effects commonly associated with traditional iron supplements.

The need to know

What are the benefits?

Highly absorbable liposomal iron. Reduces gastrointestinal issues normally associated with iron supplements.

The Science

Liposomal encapsulation technology enhances the bioavailability of iron by encasing it within phospholipid vesicles, facilitating direct transport into the bloodstream and improving cellular uptake. This method increases absorption rates and reduces gastrointestinal discomfort, such as nausea and constipation, often associated with conventional iron supplements.

Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients: This study (3) found that oral liposomal iron was non-inferior to injectable iron sucrose, suggesting it is an effective alternative to intravenous iron therapy.

Treatment of Iron Deficiency Anemia with Liposomal Iron in Inflammatory Bowel Disease Patients: Liposomal iron significantly improved haemoglobin and ferritin levels with minimal side effects in IBD patients. (2)

Efficacy and Safety of Oral Supplementation with Liposomal Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease: This study demonstrated that liposomal iron effectively increased patient transferrin saturation, indicating improved iron status. (1)

Safety and Efficacy of Oral Liposomal Iron Supplemented in Cancer Patients Receiving Chemotherapy and Epoetin Alfa: The research indicated that liposomal iron supplementation increased haemoglobin levels without significant adverse effects, supporting its use in oncology settings. (4)

How will I know its working?

1 week of liposomal iron has been shown to be equivalent to an intravenous infusion of iron.

When to take it?

Take one capsule per day with or without food

Ingredients

Active Ingredients	Amount Per Serving	% Daily Value
Iron (elemental) in liposomal form as ferrous fumarate	25mg	179%
Other ingredients: Phospholipids (non-GMO Sunflower), Iron (as Ferrous Fumarate), Maltodextrin (protectant), Capsule Shell (Hydroxypropyl Methylcellulose).

Did you know?

Publications you might find interesting

Want to go a bit deeper?

The latest research

1. Cesarano D, Borrelli S, Campilongo G, D'Ambra A, Papadia F, Garofalo C, De Marco A, Marzano F, Ruotolo C, Gesualdo L, Cirillo P, Minutolo R. Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency. Nutrients. 2024 Apr 24;16(9):1255. doi: 10.3390/nu16091255. PMID: 38732502; PMCID: PMC11085822.

2. de Alvarenga Antunes CV, de Alvarenga Nascimento CR, Campanha da Rocha Ribeiro T, de Alvarenga Antunes P, de Andrade Chebli L, Martins Gonçalves Fava L, Malaguti C, Maria Fonseca Chebli J. Treatment of iron deficiency anemia with liposomal iron in inflammatory bowel disease: efficacy and impact on quality of life. Int J Clin Pharm. 2020 Jun;42(3):895-902. doi: 10.1007/s11096-020-01044-x. Epub 2020 May 5. PMID: 32367457.

3. Bengelloun Zahr S, Allata Y, El Mansoury M, Chouhani BA, Kabbali N, El Bardai G, Sqalli Houssaini T. Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-dialysis Chronic Kidney Disease Patients: A Non-inferiority Study. Cureus. 2024 Sep 24;16(9):e70114. doi: 10.7759/cureus.70114. PMID: 39449947; PMCID: PMC11501097.

4. Safety and Efficacy of Oral Liposomal Iron Supplemented in Cancer Patients with Chemotherapy-Related Anemia Receiving Epoetin Alfa. Final Data
Prestifilippo, A. et al.
Annals of Oncology, Volume 23, ix505